Linda Copeland
About Linda Copeland
Linda Copeland is a Senior Enrollment Specialist at Bristol-Myers Squibb in New York with over 30 years of experience in the pharmaceutical and healthcare industry.
Title: Senior Enrollment Specialist
Linda Copeland currently holds the position of Senior Enrollment Specialist at Bristol-Myers Squibb. She is based in New York, New York, United States. With her extensive background in patient recruitment and clinical data management, she plays a pivotal role in enrolling participants for clinical trials at the pharmaceutical giant.
Professional Background and Career History
Linda Copeland has a robust history in the pharmaceutical and healthcare industry, spanning over 30 years. She commenced her career as the owner of Sumpthin Special from 1980 to 1983. She has held various significant roles in major companies. This includes working at Knoll Pharmaceutical as a Data Manager from 1990 to 1991, Johnson & Johnson Pharmaceutical Research Institute as Associate Director Patient Recruitment from 1993 to 2003, PRA as Manager of Clinical Data Management from 1995 to 1996, Target as Director Project Management in 1998, Novartis as Clinical Research Manager Oncology from 2002 to 2011, and continuing in her current role at Bristol-Myers Squibb.
Experience in Clinical Trials and Data Management
Linda Copeland has amassed significant experience in clinical trials and data management throughout her career. Her role as Clinical Research Manager Oncology at Novartis saw her managing clinical trials, and at Johnson & Johnson, she focused on patient recruitment for a decade. In these roles, she was responsible for overseeing data management processes and ensuring the effective recruitment and retention of clinical trial participants.
Academic Background
Linda Copeland pursued her studies at Hunterdon Medical Center from 2013 to 2015 for two years. This education, coupled with her extensive professional experience, has solidified her expertise in clinical research and data management within the pharmaceutical industry.